
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 990 | 1158 | 1129 | 2193 | 4518 | 5323 |
Fund Return | -1.03% | 15.81% | 12.94% | 29.92% | 35.2% | 18.2% |
Place in category | 43 | 153 | 45 | 7 | 18 | 12 |
% in Category | 38 | 81 | 18 | 4 | 10 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC Balan Adv Direct Dividend Pay | 1,002.99B | 3.43 | 22.30 | 11.53 | ||
INF179K01830 | 1,002.99B | 3.19 | 21.55 | 14.00 | ||
HDFC MidCap Opportunities Div | 797.18B | -1.25 | 29.06 | 17.21 | ||
HDFC MidCap Opportunities Growth | 797.18B | -1.28 | 29.05 | 17.48 | ||
HDFC MidCap Opportunities Dir Gr | 797.18B | -1.04 | 29.91 | 18.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC MidCap Opportunities Dir Gr | 797.18B | -1.04 | 29.91 | 18.42 | ||
HDFC MidCap Opportunities Div | 797.18B | -1.25 | 29.06 | 17.21 | ||
HDFC MidCap Opportunities Growth | 797.18B | -1.28 | 29.05 | 17.48 | ||
Kotak Emerging Equity Scheme Divide | 496.46B | -3.58 | 23.49 | 17.30 | ||
Kotak Emerging Equity Scheme Growth | 496.46B | -3.58 | 23.49 | 17.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Max Financial | INE180A01020 | 4.81 | 1,595.30 | +1.21% | |
Federal Bank | INE171A01029 | 3.24 | 207.51 | +1.76% | |
Coforge | INE591G01025 | 3.22 | 1,832.00 | +2.12% | |
Balkrishna Industries | INE787D01026 | 2.94 | 2,420.40 | +0.69% | |
Ipca Laboratories | INE571A01038 | 2.91 | 1,354.40 | -0.57% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review